Inventor · disambiguated record
Harry M. Lander
Also filed as: LANDER HARRY · LANDER HARRY M
4 granted patents·7 pending applications·6 citations·filing 2017–2023
65Inventor score
Top patents by PatentIndex Score
11 records- 0184US11141471B2Universal donor checkpoint inhibitor silenced/gene edited cord blood killer cellsREGEN BIOPHARMA INC·Filed 2017·Granted Oct 12, 2021·3 cites·13 claims
- 0278US10472351B2Small molecule agonists and antagonists of NR2F6 activity in animalsZANDER THERAPEUTICS INC·Filed 2018·Granted Nov 12, 2019·2 cites·3 claims
- 0371US11324719B2Small molecule agonists and antagonists of NR2F6 activity in humansKCL THERAPEUTICS INC·Filed 2017·Granted May 10, 2022·1 cites·3 claims
- 0466US2024093205A1Dual checkpoint inhibitor aptamer based therapeuticsREGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0563US2024100160A1Enhancement of t cell homing to tumors through augmentation of chemokine responsiveness and activation dependent chemokine secretionREGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0663US2024165204A1Modulation of tumor microenvironment to augment efficacy of immunotherapyREGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0762US2024066126A1Combination therapy of solid tumors using chimeric antigen receptor cells representing adaptive and innate immunityREGEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0857US2022249436A1Small Molecule Agonists and Antagonists of NR2F6 Activity in HumansKCL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0955US2020071307A1Small molecule agonists and antagonists of nr2f6 activity in animalsZANDER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1054US11377442B2Small molecule agonists and antagonists of NR2F6 activityZANDER THERAPEUTICS INC·Filed 2018·Granted Jul 5, 2022·0 cites·4 claims
- 1133US2019054118A1Small Molecule Agonists and Antagonists of NR2F6 Activity in AnimalsZANDER THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Harry M. Lander files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →